|24th February 2021||Richard M. Sanders||138,376||Exercise of derivative||$0.95||$131,457.20|
|24th February 2021||Nora B Sullivan||138,376||Exercise of derivative||$0.95||$131,457.20|
|26th January 2021||Nora B Sullivan||690||Grant/award etc.||$29.71||$20,499.90|
|13th December 2020||Michael Zercher||18,583||Payment by withholding||$2.54||$47,200.82|
|17th November 2020||James A Mish||100,000||Open or private purchase||$0.93||$92,800.00|
|29th June 2020||Nora B Sullivan||22,000||Open or private purchase||$0.78||$17,160.00|
|22nd June 2020||James A Mish||150,000||Grant/award etc.||$0.00|
|8th June 2020||John Franzino||50,000||Grant/award etc.||$0.00|
|5th June 2020||Nora B Sullivan||29,953||Open or private purchase||$0.82||$24,561.46|
|4th June 2020||Nora B Sullivan||71,372||Open or private purchase||$0.82||$58,660.65|
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.
22nd Century Group, Inc. is a plant biotechnology company. Its products include X-22, modified risk cigarettes, spectrum government research cigarettes, magic 0 and magic 2, moonlight, red sun, variable nicotine-level research cigarettes.